Analysis of Antibody Fragment-Drug Conjugates Using an Agilent AdvanceBio SEC 120 Å 1.9 μm PEEK-Lined Column
Applications | 2021 | Agilent TechnologiesInstrumentation
Consumables, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsfdc, scfv, counts, dar, antibody, drug, deconvoluted, amu, sec, native, linker, mass, lined, desalting, method, conjugates, charge, gas, dual, phase, mobile, antikor, fdcs, protonating, stenton, fvs, scfvs, peek, agilent, benjamin, conjugating, size, monitoring, jet, neutral, sheath, qin, veronica, stream, acquisition, chain, superior, sodium, coffey, payload, desalt, reversed, mimics, using, phases
Similar PDF
Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
2021|Agilent Technologies|Applications
Application Note Biopharma/Pharma Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS Authors David L. Wong and Sarah M. Stow Agilent Technologies, Inc. Abstract Antibody drug conjugates (ADCs), which comprise a monoclonal antibody (mAb) conjugated to a small molecule drug…
Key words
dimension, dimensiondar, daradcs, adcsadc, adcsecond, secondnative, nativehic, hicadvancebio, advancebiocounts, countsmab, mabdrug, drugdeconvoluted, deconvolutedfirst, firstconjugated, conjugatedintact
Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC
2016|Agilent Technologies|Applications
Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC Application Note Biologics & Biosimilars Author Abstract Sonja Schneider Recombinant monoclonal antibodies (mAbs) have emerged as important Agilent Technologies, Inc. therapeutic agents…
Key words
adcs, adcsdeconvoluted, deconvolutedadc, adctrastuzumab, trastuzumabdeglycosylated, deglycosylatedmass, masscounts, countsdrug, drugantibody, antibodysec, seclinker, linkerspectrum, spectrumcharge, chargedar, darconjugates
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry
2017|Agilent Technologies|Applications
Analysis of Antibody-Drug Conjugates Using Size Exclusion Chromatography and Mass Spectrometry Application Note Biologics and Biosimilars Author Abstract Sonja Schneider Recombinant monoclonal antibodies (mAbs) have emerged as important Agilent Technologies, Inc. therapeutic agents for the treatment of different diseases. This…
Key words
trastuzumab, trastuzumabadcs, adcsadc, adcemtansine, emtansinedeconvoluted, deconvolutedcounts, countsdrug, drugdeglycosylated, deglycosylatedamu, amusec, secmass, massmabs, mabsbuffer, bufferspectrum, spectrumantibody
Native SEC/MS Analysis of mAbs on an Entirely Biocompatible Flow Path
2023|Agilent Technologies|Applications
Application Note Biopharma/Pharma Native SEC/MS Analysis of mAbs on an Entirely Biocompatible Flow Path Using the Agilent 1290 Infinity II Bio LC System and Agilent AdvanceBio SEC 200 Å 1.9 µm PEEK-lined column in mAbs analysis Authors Abstract Liesa Verscheure,…
Key words
sec, secretention, retentionpeek, peekmin, mincolumn, columnnistmab, nistmabmau, maunative, nativesst, sstbio, biotime, timedeconvoluted, deconvolutedresponse, responselined, linedhmw